The mRNA expression of BRCA1, RRM1 and RRM2 is potentially a useful tool for selecting NSCLC patients for individualized chemotherapy and warrants further investigation in prospective studies. The gene discussed is BRCA1; the disease is non-small cell lung carcinoma.